Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Theravance Biopharma Reports Q2 2026 Results

Theravance Biopharma, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 11, 2026, covering the period ended June 30, 2026, and disclosing a net loss of $10.831 million for the first half of the year alongside …

Anjali Anand | 11 August 2026

Smithfield Foods Reports Q2 2026 Financial Results

Smithfield Foods, Inc. filed its Form 10-Q for the quarterly period ended June 28, 2026 with the U.S. Securities and Exchange Commission on August 11, 2026, disclosing income statements, balance sheet data, and cash flow results for the three and six months ended June …

Aditi Sarkar | 11 August 2026

Prelude Therapeutics Posts Q2 2026 Results With New Revenue

Prelude Therapeutics Incorporated filed its Form 10-Q for the quarterly period ended June 30, 2026, with the U.S. Securities and Exchange Commission, reporting its first period of recognized revenue alongside a narrowed net loss compared to the prior year.

Nitish Kishor | 11 August 2026

Cardinal Health Enters $4 Billion Revolving Credit Agreement

Cardinal Health, Inc. filed a Form 8-K on August 11, 2026, reporting that on August 7, 2026, the company entered into a new $4.0 billion unsecured revolving credit agreement and simultaneously terminated three prior credit and receivables facilities.

Aakashdeep | 11 August 2026

Cardinal Health Files Fiscal 2026 Annual Report

Cardinal Health, Inc. filed its Form 10-K for the fiscal year ended June 30, 2026, with the U.S. Securities and Exchange Commission on August 11, 2026, covering operations across its Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution segments.

Shwetambri Chauhan | 11 August 2026

Cardinal Health Reports Q4 and Full-Year Fiscal 2026 Results

Cardinal Health, Inc. filed a Form 8-K with the SEC on August 11, 2026, announcing its financial results for the quarter and fiscal year ended June 30, 2026, and disclosing a webcast during which management will also discuss the fiscal year 2027 outlook.

Shwetambri Chauhan | 11 August 2026

Investors Title Company Reports Q2 2026 Financial Results

Investors Title Company filed its Form 10-Q for the quarterly period ended June 30, 2026 with the Securities and Exchange Commission, reporting net income of $14,633 thousand for the second quarter and $20,700 thousand for the first six months of the year.

Vinay Lochav | 10 August 2026

BTC Development Corp. Files Q2 2026 Form 10-Q

BTC Development Corp. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 10, 2026, covering the quarter ended June 30, 2026.

Aditi Sarkar | 10 August 2026

FirstSun Capital Bancorp Executive Chair Files Form 4

Mollie H. Carter, Executive Chair and Director of FirstSun Capital Bancorp (NASDAQ: FSUN), filed a Form 4 on August 10, 2026, disclosing a transfer of 5,165 shares of common stock on May 20, 2026.

Shwetambri Chauhan | 10 August 2026

FirstSun Capital Bancorp Files Q2 2026 Form 10-Q

FirstSun Capital Bancorp filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 10, 2026, covering the quarterly period ended June 30, 2026.

Anjali Anand | 10 August 2026
Support

Hi! How can we help you today?

Loading…